Ramchandani, B., & Mirza, F. S. (2024). Effectiveness of romosozumab in primary biliary cholangitis at half the recommended dose in an underweight patient. Elsevier.
Chicago Style (17th ed.) CitationRamchandani, Bhanvi, and Faryal Sardar Mirza. Effectiveness of Romosozumab in Primary Biliary Cholangitis at Half the Recommended Dose in an Underweight Patient. Elsevier, 2024.
MLA (9th ed.) CitationRamchandani, Bhanvi, and Faryal Sardar Mirza. Effectiveness of Romosozumab in Primary Biliary Cholangitis at Half the Recommended Dose in an Underweight Patient. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.